相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。GEC-ESTRO ACROP prostate brachytherapy guidelines
Ann Henry et al.
RADIOTHERAPY AND ONCOLOGY (2022)
HDR brachytherapy as monotherapy for prostate cancer: A systematic review with meta-analysis
Gustavo Arruda Viani et al.
BRACHYTHERAPY (2021)
Single-fraction HDR brachytherapy as monotherapy in low and intermediate risk prostate cancer: Outcomes from two clinical trials with and without an MRI-guided boost
Yasir Alayed et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Dosimetry of local failure with single dose 19 Gy high-dose-rate brachytherapy for prostate cancer
Shreya Armstrong et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Ultra-hypofractionated radiotherapy for low- and intermediate risk prostate cancer: High-dose-rate brachytherapy vs stereotactic ablative radiotherapy
Yat Man Tsang et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Safety and Efficacy of Virtual Prostatectomy With Single-Dose Radiotherapy in Patients With Intermediate-Risk Prostate Cancer Results From the PROSINT Phase 2 Randomized Clinical Trial
Carlo Greco et al.
JAMA ONCOLOGY (2021)
Impact of hydrogel and hyaluronic acid rectal spacer on rectal dosimetry and toxicity in low-dose-rate prostate brachytherapy: a multi-institutional analysis of patients' outcomes
Yuan-Hong Lin et al.
JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2021)
Single dose high-dose rate (HDR) brachytherapy (BT) as monotherapy for localised prostate cancer: Early results of a UK national cohort study
Hannah Tharmalingam et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Pattern of relapse and dosimetric analysis of a single dose 19 Gy HDR-brachytherapy phase II trial
Alfonso Gomez-Iturriaga et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Prostate high dose -rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy
Gerard Morton et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Five-Year Outcomes of a Single-Institution Prospective Trial of 19-Gy Single-Fraction High-Dose-Rate Brachytherapy for Low- and Intermediate-Risk Prostate Cancer
Zaid A. Siddiqui et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Single-fraction brachytherapy as monotherapy for early-stage prostate cancer: The UCSF experience
Melody J. Xu et al.
BRACHYTHERAPY (2019)
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
Anders Widmark et al.
LANCET (2019)
Single fraction high-dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: toxicities and early outcomes from a single institutional experience
Justin M. Barnes et al.
JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2019)
High-dose-rate interstitial brachytherapy as monotherapy in one fraction of 20.5 Gy for the treatment of localized prostate cancer: Toxicity and 6-year biochemical results
Pedro J. Prada et al.
BRACHYTHERAPY (2018)
Single-dose high-dose-rate brachytherapy compared to two and three fractions for locally advanced prostate cancer
Peter Hoskin et al.
RADIOTHERAPY AND ONCOLOGY (2017)
High-dose-rate brachytherapy boost for prostate cancer: Comparison of three different fractionation schemes
Alexander T. Falk et al.
BRACHYTHERAPY (2017)
High-dose-rate interstitial brachytherapy as monotherapy in one fraction for the treatment of favorable stage prostate cancer: Toxicity and long-term biochemical results
Pedro J. Prada et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: Potential for dose escalation
ICJ Hsu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
分享论文
